TRILACICLIB

Clinical trials for TRILACICLIB explained in plain language.

Never miss a new study

Get alerted when new TRILACICLIB trials appear

Sign up with your email to follow new studies for TRILACICLIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New shield for chemo patients: can trilaciclib prevent dangerous side effects?

Disease control Recruiting now

This study tests a drug called trilaciclib to protect bone marrow in people with solid tumors receiving chemotherapy. The goal is to reduce severe drops in blood cells, which can be dangerous and delay treatment. Researchers will build a model to predict who benefits most from th…

Matched conditions: TRILACICLIB

Phase: PHASE1 • Sponsor: Hebei Medical University Fourth Hospital • Aim: Disease control

Last updated Jun 27, 2026 12:00 UTC

TRILACICLIB

Get alerted when new TRILACICLIB trials appear

New shield for chemo patients: can trilaciclib prevent dangerous side effects?